Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORSEL PHARMA AS
AS
Active
Org 931329359
Tollbugata 115, 3041 Drammen
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+29% vs 2023
Equity ratio
44.2%
Financial strength
Net profit 2024
NOK -372K
+18% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
-1M
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -411K
+29%
Net profit
NOK -372K
+18%
Total assets
NOK -1,8M
-293%
Equity
NOK -803K
-86%
Employees
0
—
Company information
Legal name
NORSEL PHARMA AS
Org number
931329359
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. mai 2023
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Utvikler, produserer, markedsfører og selger kosttilskudd, kosmetikk og kroppspleieprodukter.
Contact
Address
Tollbugata 115, 3041 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Drammen
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
-1M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−578
−411
Depreciation & amort.
−0
−0
EBIT
−578
−411
Net financials
−5
−66
Profit before tax
−584
−477
Tax
−128
−105
Net profit
−455
−372
Balance sheet
NOK thousands
Item
2023
2024
Total assets
944
−1 817
Equity
−431
−803
Long-term debt
0
0
Short-term debt
1 374
−1 014
Total debt
1 374
−1 014
Financial ratios
5-year trend
EBITDA margin
-41109400.0%
This company
15.8%
Market median
-260186176% vs market
2023
2024
Equity ratio
-80259400.0%
This company
38.2%
Market median
-210103241% vs market
2023
2024
Return on equity
-37189200.0%
This company
18.4%
Market median
-202115317% vs market
2023
2024
Net profit margin
-37189200.0%
This company
8.1%
Market median
-459126026% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
-1.26×
This company
0.62×
Market median
+303% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MN
Monica Nguyen
Chairman
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Khiem Holding As
Company
50%
50%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Khiem Holding As
NORSEL PHARMA AS
(this company)
Board network connections
Board members of NORSEL PHARMA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Monica Nguyen
Chairman
0 companies